THE ECOLOGICAL SOCIETY OF AMERICA VOICES ITS CONCERNS ISB News Report, USA, by Michelle Marvier http://www.isb.vt.edu/news/2004/news04.may.html 5 May 2004 THE ECOLOGICAL SOCIETY OF AMERICA VOICES ITS CONCERNS Almo […]
|
||||||
|
Ann Clark of Guelph University talks about the lack of scientific credibility in the biotechnology industry’s claims about the safety of GMOs and the need for more and better testing of GM food and crops based on sound science. […] Biotechnology is considered both as an industry and as a technology which will spur the development of the countries of the South and lift them out of poverty. The following article considers whether there is any justification for this. […] Debashis Banerji, a plant physiologist, believes the failure of Bt cotton illustrates the fact that genetic engineering as practised today is based on an over-simplified understanding of the “central dogma” of molecular biology. […] According to the Greenpeace report, diverse species of Roundup resistant weeds are now growing in Roundup Ready GE crop fields in several states in the US. It has become clear that growing and releasing GE seeds not only involves an incalculable risk to t […] Will GM crops really help developing countries? Lim Li Ching looks at some telling examples in Kenya, Indonesia and India. […] Will GM crops really help developing countries? Lim Li Ching looks at some telling examples in Kenya, Indonesia and India. […] Item 1 Liver of Mice Fed GM Soya Works Overtime The liver cells of mice fed GM soya are more active in gene expression. Dr. Mae-Wan Ho reports on further evidence that GM feed affects the physiology of animals for reasons yet unknown […] Monsanto, the world’s leader in developing and marketing GE seeds, is at a risk of financial setback if it continues with its current business focus on GE-related products, says Innovest Strategic Value Advisors in a report commissioned by Greenpeace. […] An analysis showed that the company faces risks from producing GE foods that include product liability, biopharm contamination, consumer rejection and insurance industry concern, thus raises questions to its economic viability. […] |
||||||
|
All our content may be republished or reused for free, except where otherwise noted. This site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Powered by WordPress & Atahualpa |
||||||